Crinetics Pharmaceuticals
CRNX
#3268
Rank
ยฃ3.32 B
Marketcap
ยฃ35.01
Share price
-1.58%
Change (1 day)
-21.16%
Change (1 year)

Revenue for Crinetics Pharmaceuticals (CRNX)

Revenue in 2025 (TTM): ยฃ1.13 Million

According to Crinetics Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ1.15 Million. In 2024 the company made a revenue of ยฃ0.82 Million a decrease over the revenue in the year 2023 that were of ยฃ3.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Crinetics Pharmaceuticals from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.13 M37.28%
2024 ยฃ0.82 M-73.72%
2023 ยฃ3.14 M-19.55%
2022 ยฃ3.91 M390.29%
2021 ยฃ0.79 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA